Skip to main content
. Author manuscript; available in PMC: 2024 Mar 23.
Published in final edited form as: Arch Pathol Lab Med. 2021 Apr 1;145(4):419–427. doi: 10.5858/arpa.2020-0008-OA

Table 3.

Results of Paired Pre–Direct-Acting Antiviral Agent (DAA) Therapy and Post–DAA Therapy Biopsies

Sex Age, y Pre-Tx Grade Pre-Tx Stage Pre-Tx PIR DAA-SVR Grade DAA-SVR Stage DAA-SVR PIR Duration of Tx, wk Time Interval Between Biopsies, y

Male 41 1 1 2 2 12 18
Male 60 2 2 1 2 12 2
Female 56 3 2 1 4 12 6
Male 62 2 4 I 1 4 P 12 2
Female 53 2 2 0 2 12 1
Male 66 3 3 0 2 12 5
Male 61 4 3 2 2 N/A 17
Male 64 3 4 P 3 4 P 24 2
Male 64 2 2 2 4 I 12 2
Male 61 2 4 P 2 4 I 24 16
Male 64 2 4 P 1 4 R 24 1
Male 63 3 4 P 2 4 P 24 11
Male 50 3 4 P 1 4 P 26 10
Male 66 2 4 P 1 3–4 R 45 2

Abbreviations: N/A, not available; PIR, progressive, indeterminate, and regressive fibrosis; SVR, sustained viral response; Tx, therapy.